Evidence map›Paper›PMID 42405093›Full record

ReviewRSC advances2026

Recent advances in metal sulfide nanozymes for sensing.

Astha Tripathi, Ishwar Dutt Vats, Karishma Bisht, Pratibha Kumari

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Astha TripathiDepartment of Chemistry, University of Delhi New Delhi-110007 India.
Ishwar Dutt VatsDepartment of Chemistry, Deshbandhu College, University of Delhi Kalkaji New Delhi-110019 India pkumari@db.du.ac.in.
Karishma BishtDepartment of Chemistry, Deshbandhu College, University of Delhi Kalkaji New Delhi-110019 India pkumari@db.du.ac.in.
Pratibha KumariDepartment of Chemistry, Deshbandhu College, University of Delhi Kalkaji New Delhi-110019 India pkumari@db.du.ac.in.ORCID https://orcid.org/0000-0002-3830-3926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal sulfide nanozymes have emerged as a highly promising class of catalytic nanomaterials for sensing applications due to their tunable activity, operational stability, and facile synthesis. Their sulfur-rich frameworks can promote electron transfer and the generation of reactive oxygen species, thereby enhancing signal amplification in colorimetric, electrochemical, and other sensing platforms. These attributes have enabled the sensitive detection of a broad range of analytes, including metal ions, pesticides, biomolecules, hydrogen peroxide, phenolics, and dyes, and have supported their integration into portable and point-of-care diagnostic devices. Despite rapid progress, the field remains fragmented by several unresolved challenges, including an incomplete understanding of structure-activity relationships, limited standardization of catalytic activity evaluation, and insufficient validation of selectivity in complex biological matrices. This review critically examines recent advances in metal sulfide nanozymes, focusing on their preparation strategies, catalytic mechanisms, and sensing applications. Unlike existing nanozyme reviews, this article specifically emphasizes how compositional modulation, defect engineering, heterostructure construction, and surface functionalization govern sensing performance in metal sulfide systems. By identifying major limitations and outlining future directions for mechanistic study, this review aims to provide a more focused framework for advancing metal sulfide nanozymes toward practical biomedical and environmental applications.

Identifiers

PMID42405093
PMCPMC13329686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.